论文部分内容阅读
目前,支气管哮喘仍是一种常见病和多发病,具有气道广泛的可变性阻塞及气道高反应性的特点。该病的传统治疗药物包括氨茶碱、肾上腺素、异丙肾上腺素、激素等。但这些药物如长期应用不但会疗效逐渐下降,而且会产生许多副作用,使其使用受到限制。近年发现不少非平喘药物在治疗或辅助治疗支气管哮喘方面显示了巨大潜力,成为一类治疗支气管哮喘病不可忽视的“平喘药”。
Currently, bronchial asthma is still a common disease and frequently-occurring disease, with extensive variability of airway obstruction and airway hyperresponsiveness. Traditional remedies for the disease include aminophylline, epinephrine, isoproterenol, hormones and the like. However, if these drugs are used for a long time, the curative effect will not only be gradually reduced but also many side effects will be caused, which will limit their use. In recent years, many non-antiasthmatic drugs found in the treatment or adjuvant treatment of bronchial asthma has shown great potential to become a class of treatment of bronchial asthma can not be ignored “antiasthmatic medicine.”